Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
Yamashita T, Shimada H, Tanaka S, Araki K, Tomifuji M, Mizokami D, Tanaka N, Kamide D, Miyagawa Y, Suzuki H, Tanaka Y, Shiotani A.
Yamashita T, et al. Among authors: tanaka n, tanaka s, tanaka y.
Cancer Med. 2016 Mar;5(3):415-25. doi: 10.1002/cam4.600. Epub 2016 Jan 22.
Cancer Med. 2016.
PMID: 26798989
Free PMC article.